Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC12A7 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
mRNA | HK1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
mRNA | FAM213A | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
mRNA | ZNF726 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
mRNA | SLC36A4 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
mRNA | GAGE12B | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
mRNA | BRAF | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
mRNA | FAM168A | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
mRNA | CTU2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
mRNA | VGLL4 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |